« Back to Medicines list

Minims Atropine Sulphate 1%w/v, Eye drops solution

  • Name:

    Minims Atropine Sulphate 1%w/v, Eye drops solution

  • Company:
    info
  • Active Ingredients:

    Atropine sulfate

  • Legal Category:

    Product subject to medical prescription which may be renewed (B)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 21/05/20

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 21/5/2020

Click on this link to Download PDF directly

Bausch Health Ireland Ltd.

Bausch & Lomb U

Company Products

Medicine NameActive Ingredients
Medicine Name Artelac, Eye drops solution Active Ingredients Hypromellose
Medicine Name Artelac, SDU, Eye drops solution Active Ingredients Hypromellose
Medicine Name Emerade, 150 micrograms, solution for injection in pre-filled pen Active Ingredients Adrenaline tartrate
Medicine Name Emerade, 300 micrograms, solution for injection in pre-filled pen Active Ingredients Adrenaline tartrate
Medicine Name Emerade, 500 micrograms, solution for injection in pre-filled pen Active Ingredients Adrenaline tartrate
Medicine Name GelTears, Eye Gel Active Ingredients Carbomer
Medicine Name Liposic 2mg/g Eye Gel Active Ingredients Carbomer
Medicine Name Lotemax 0.5% Eye Drops, Suspension Active Ingredients Loteprednol Etabonate
Medicine Name Megace 160mg Tablets Active Ingredients megestrol acetate
Medicine Name Megace 40mg/ml oral suspension Active Ingredients megestrol acetate
Medicine Name Minims Artificial Tears, Eye drops solution Active Ingredients Hyetellose, Sodium Chloride
Medicine Name Minims Atropine Sulphate 1%w/v, Eye drops solution Active Ingredients Atropine sulfate
Medicine Name Minims Chloramphenicol 0.5% w/v, Eye drops solution Active Ingredients Chloramphenicol
Medicine Name Minims Cyclopentolate Hydrochloride 1.0% w/v, Eye drops solution Active Ingredients Cyclopentolate Hydrochloride
Medicine Name Minims Fluorescein Sodium 1%, Eye drops solution Active Ingredients Fluorescein Sodium
Medicine Name Minims Fluorescein Sodium 2%, Eye drops solution Active Ingredients Fluorescein Sodium
Medicine Name Minims Lidocaine & Fluorescein. Active Ingredients Fluorescein Sodium, Lidocaine Hydrochloride
Medicine Name Minims Oxybuprocaine Hydrochloride 0.4% w/v eye drop solution Active Ingredients Oxybuprocaine Hydrochloride
Medicine Name Minims Phenylephrine Hydrochloride 2.5%, Eye drops solution Active Ingredients Phenylephrine Hydrochloride
Medicine Name Minims Pilocarpine Nitrate 2% w/v, Eye drops solution Active Ingredients Pilocarpine nitrate
Medicine Name Minims Povidone Iodine 5% w/v eye drops, solution Active Ingredients Povidone Iodine
Medicine Name Minims Prednisolone Sodium Phosphate 0.5% Active Ingredients Prednisolone Sodium Phosphate
Medicine Name Minims Proxymetacaine 0.5% w/v, Eye Drops Solution Active Ingredients Proxymetacaine hydrochloride
Medicine Name Minims Saline Active Ingredients Sodium Chloride
Medicine Name Minims Tetracaine Hydrochloride 0.5% w/v, Eye drops solution Active Ingredients Tetracaine hydrochloride
1 - 0 of 33 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 21 May 2020 PIL

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - marketing authorisation number
  • Change to section 6 - date of revision

Updated on 21 May 2020 SmPC

Reasons for updating

  • New SmPC for medicines.ie

Legal category: Product subject to medical prescription which may be renewed (B)

Updated on 29 July 2015 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Product subject to medical prescription which may be renewed (B)

Updated on 29 July 2015 SmPC

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

change in marketing authorisation  holder and date of revision of text

Updated on 28 July 2015 PIL

Reasons for updating

  • New PIL for new product

Updated on 28 July 2015 PIL

Reasons for updating

  • Change to date of revision
  • Change to marketing authorisation holder

Updated on 1 August 2013 PIL

Reasons for updating

  • Correction of spelling/typing errors

Updated on 30 August 2012 PIL

Reasons for updating

  • Correction of spelling/typing errors

Updated on 25 July 2012 SmPC

Reasons for updating

  • Correction of spelling/typing errors

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

All SPCs on Medicines.ie have been updated for Bausch + Lomb following personnel changes to ensure accuracy of information.

Updated on 13 August 2010 SmPC

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 6.1 - List of excipients
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

1.       NAME OF THE MEDICINAL PRODUCT

 

          Minims Atropine Sulphate 1% w/v Eye Drops, solution.

 

2.       QUALITATIVE AND QUANTITATIVE COMPOSITION

 

          Atropine Sulphate 1% w/v.

 

          For a full list of excipients, see section 6.1.

 

6.1     List of Excipients

 

                   Hydrochloric acid (for pH adjustment)

                   Purified water

 


6.6     Special precautions for disposal of a used medicinal product or waste materials derived from such medicinal product and other handling of the product

 

                   For single use only. Discard any remaining solution.

 

9.       DATE OF FIRST AUTHORISATION/RENEWAL OF AUTHORISATION

 

          1 April 1979/ 1st April 2009

 

10.     DATE OF REVISION OF THE TEXT

          October 2009

Updated on 17 May 2005 SmPC

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 6.2 - Incompatibilities
  • Change to section 6.4 - Special precautions for storage
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may be renewed (B)

Updated on 16 May 2005 PIL

Reasons for updating

  • New PIL for medicines.ie

Updated on 16 May 2005 SmPC

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 6.2 - Incompatibilities
  • Change to section 6.4 - Special precautions for storage
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may be renewed (B)

Updated on 22 August 2003 SmPC

Reasons for updating

  • Improved electronic presentation

Legal category: Product subject to medical prescription which may be renewed (B)

Updated on 20 August 2003 SmPC

Reasons for updating

  • Change to section 10 - Date of revision of the text

Legal category: Product subject to medical prescription which may be renewed (B)

Updated on 16 July 2003 SmPC

Reasons for updating

  • New SPC for medicines.ie

Legal category: Product subject to medical prescription which may be renewed (B)